I totally agree with you. You did a wonderful over
Post# of 148304
He made no claims to CTC or Caml testing or any future projections. That was the only thing that could of made it more impressive. We know that Nader said that CTC’s counts were close to zero in the basket trial participants. This albeit early would maybe or could of knocked the socks off of a few people attending. It sure keeps knocking the socks off of me. Overall presentation should open some eyes and start many conversations about immunology in Cancer and Leronlimab.
Now all we need is for the same presentation in a pre-BTD FDA meeting with the results so far so we can get some attention and have the FDA know that Leronlimab is for real and we aren’t going away. We are here to save lives and all though we know it’s a tight club... we are bustin the rules and breaking into the club house. Because once we get in that club house... we are going to take it over!
CYTODYN the future of Cancer Treatment for Solid Tumor Indications.
All 23 deadliest cancers in the world at our feet for us to possibly help cure or at the very least add critical life extending time to cancer patients. These trials could prove out to be everything we ever dreamed Leronlimab would achieve. Just take a second to think about that... it’s beyond huge. If you haven’t figured it out yet... Cancer is by far the biggest indication we could ever hope for.